In this issue:
FRUTIGA: fruquintinib + paclitaxel for advanced gastric/GOJ adenocarcinoma
Claudin18.2-specific CAR T-cell therapy in GI cancers
Neoadjuvant nivolumab ± relatlimab in resectable oesophageal/GOJ cancer
TOPAZ-1: durvalumab + gemcitabine-cisplatin in advanced biliary tract cancer
ATTRACTION-5: adjuvant nivolumab + chemotherapy for resected stage 3 gastric/GOJ cancer
NALIRICC: nanoliposomal irinotecan + fluorouracil + leucovorin in biliary tract cancer
EPIC: early palliative care for metastatic upper GI cancers & OS
Long-term discontinuation vs. continuation of imatinib for advanced GIST
T-DXd in HER2-positive/HER2-low biliary tract cancer
Pertuzumab + trastuzumab in biliary tract cancer with HER2/3 alterations
Please login below to download this issue (PDF)